Priority Date: 20.07.10 (US 20100366095P)

HIGH TELOMERASE ACTIVITY BONE MARROW MESENCHYMAL STEM CELLS, METHODS OF PRODUCING THE SAME AND PHARMACEUTICALS AND TREATMENT METHODS BASED THEREON

  • Application ID: EP11810369
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 51 - 200 employees
Company dna viering jentschura and partner
operating since 1976
Headquarter in Munich and 7 offices
active in Legal Services, IP Consulting, and IP-related Communication Service

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 184 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 20.07.2010 - Priority Date (US 20100366095P)
  • 26.01.2012 - Publication A2 (WO2012012570)
  • 29.05.2013 - Publication A2 (EP2596097)

IPC Classification